[Lipoprotein (a) in physiological states and kidney diseases].
The present paper is a concise summary of contemporary knowledge of lipoprotein(a). Increased lipoprotein(a) concentration is an independent risk factor for atherogenesis. The treatment of choice of increased lipoprotein(a) concentration is causal--for example treatment of the nephrotic syndrome or renal transplantation. If this is not amenable, careful monitoring and elimination of additional risk factors of atherogenesis are mandatory.
Franek
E
E
Klinika Nefrologii, Endokrynologii i Chorób Metabolicznych Slaskiej Akademii Medycznej w Katowicach.
Kokot
F
F
D003324:Coronary Artery Disease / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007674:Kidney Diseases / Q000150:complications / Q000503:physiopathology* / Q000628:therapy; D017270:Lipoprotein(a) / Q000502:physiology*; D012016:Reference Values; D012307:Risk Factors
D017270:Lipoprotein(a)
Lipoproteina(a) w stanach fizjologii i w chorobach nerek.